Reevaluating the Role of Progesterone in Ovarian Cancer: Is Progesterone Always Protective?

Area of Science:

• Gynecologic Oncology
• Endocrinology
• Molecular Biology

Background:

• Ovarian cancer (OC) has high fatality rates due to late detection and subtle symptoms.
• OC typically affects post-menopausal women when ovarian hormone levels decrease.
• Progesterone is traditionally considered protective against estrogen's proliferative effects in reproductive tissues.

Purpose of the Study:

• To integrate historical and emerging research on progesterone and nuclear progesterone receptor (nPR) signaling in OC.
• To clarify the complex and potentially non-protective role of progesterone in OC development and progression.
• To provide insights for developing novel biomarkers and therapeutic strategies for OC.

Main Methods:

• Review and integration of historical perspectives on progesterone's role in OC.
• Analysis of emerging research findings on progesterone and nPR signaling in OC models.
• Critical interpretation of existing data to present a broader understanding of nPR actions.

Main Results:

• Evidence challenges the traditional view of progesterone as solely protective in OC.
• The nuclear progesterone receptor (nPR) signaling pathway is complex and integrated with other cancer-related signaling pathways.
• nPR activity can be ligand-dependent or independent, influencing OC progression.

Conclusions:

• A nuanced understanding of progesterone and nPR signaling is crucial for OC research.
• Further investigation into nPRs and nPR-driven gene regulation may reveal novel OC biomarkers.
• This research provides critical knowledge for advancing therapeutic strategies against OC.